APC and DNA demethylation in cell fate specification and intestinal cancer

Advances in Experimental Medicine and Biology

Volumn 754, Issue , 2013, Pages 167-177

  Andersen, Angela ^a   Jones, David A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; DNA GLYCOSYLTRANSFERASE; DNA METHYLTRANSFERASE; RETINOIC ACID;

APC GENE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL FATE; COLON CANCER; DISEASE ASSOCIATION; DNA METHYLATION; GENE FUNCTION; GENE LOCUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 84869068789     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9967-2_8     Document Type: Article

References (73)

1. Markowitz SD (2007) Aspirin and colon cancer-targeting prevention? N Engl J Med 356(21):2195-2198
2. Bienz M, Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103(2): 311-320
3. Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479-507
4. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87(2):159-170 (Pubitemid 26358996)
5. Sunami E et al (2011) LINE-1 hypomethylation during primary colon cancer progression. PLoS One 6(4):e18884
6. Feinberg AP et al (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48(5):1159-1161 (Pubitemid 18075525)
7. Cravo M et al (1996) Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39(3):434-438 (Pubitemid 26338534)
8. Goelz SE et al (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228(4696):187-190 (Pubitemid 15117274)
9. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759-767
10. Baker SJ et al (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50(23):7717-7722
11. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127(3):469-480
12. Sparks AB et al (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58(6):1130-1134 (Pubitemid 28183198)
13. Morin PJ et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275(5307):1787-1790 (Pubitemid 27136715)
14. Romagnolo B et al (1999) Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59(16):3875-3879 (Pubitemid 29393543)
15. Blaker H et al (2003) Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Am J Clin Pathol 120(3):418-423 (Pubitemid 37295114)
16. Anderson CB, Neufeld KL, White RL (2002) Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci USA 99(13):8683-8688 (Pubitemid 34693620)
17. Phelps RA et al (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137(4):623-634
18. Wu X et al (2008) Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133(2):340-353 (Pubitemid 351508298)
19. Caldwell CM, Green RA, Kaplan KB (2007) APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J Cell Biol 178(7):1109-1120 (Pubitemid 47480220)
20. Caldwell CM, Kaplan KB (2009) The role of APC in mitosis and in chromosome instability. Adv Exp Med Biol 656:51-64
21. Green RA, Wollman R, Kaplan KB (2005) APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 16(10):4609-4622 (Pubitemid 41416445)
22. Quyn AJ et al (2010) Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell 6(2):175-181
23. Jette C et al (2004) The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L. J Biol Chem 279(33):34397-34405 (Pubitemid 39318065)
24. Nadauld LD et al (2006) Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem 281(49): 37828-37835 (Pubitemid 46042085)
25. Nadauld LD et al (2004) Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebra fi sh intestinal development and differentiation. J Biol Chem 279(49): 51581-51589 (Pubitemid 40017909)
26. Nadauld LD et al (2005) The zebra fi sh retinol dehydrogenase, rdh1l, is essential for intestinal development and is regulated by the tumor suppressor adenomatous polyposis coli. J Biol Chem 280(34):30490-30495 (Pubitemid 41216233)
27. Mark M, Ghyselinck NB, Chambon P (2009) Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7:e002
28. Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134(6):921-931
29. Deb-Rinker P et al (2005) Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 280(8):6257-6260 (Pubitemid 40341170)
30. Fisher CL, Fisher AG (2011) Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr Opin Genet Dev 21(2):140-146
31. Wild L, Flanagan JM (2010) Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 1806(1):50-57
32. Ito S et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047):1300-1303
33. Kriaucionis S, Heintz N (2009) The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929):929-930
34. Tahiliani M et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930-935
35. Lister R et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315-322
36. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010-1022
37. Doi A et al (2009) Differential methylation of tissue- and cancer-speci fi c CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fi broblasts. Nat Genet 41(12):1350-1353
38. Irizarry RA et al (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-speci fi c CpG island shores. Nat Genet 41(2):178-186
39. Wu H et al (2010) Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329(5990):444-448
40. Shukla S et al (2011) CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 479(7371):74-79
41. Hansen KD et al (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43(8):768-775
42. Suzuki K et al (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9(3):199-207 (Pubitemid 43357946)
43. Rai K et al (2010) DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell 142(6):930-942
44. Barreto G et al (2007) Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445(7128):671-675 (Pubitemid 46232889)
45. Rai K et al (2008) DNA demethylation in zebra fi sh involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135(7):1201-1212
46. Morgan HD et al (2004) Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 279(50):52353-52360 (Pubitemid 39656611)
47. Hendrich B et al (1999) Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm Genome 10(9):906-912 (Pubitemid 29445381)
48. Wu P et al (2003) Mismatch repair in methylated DNA. Structure and activity of the mismatchspeci fi c thymine glycosylase domain of methyl-CpG-binding protein MBD4. J Biol Chem 278(7):5285-5291 (Pubitemid 36801043)
49. Blanc V et al (2007) Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice. Cancer Res 67(18):8565-8573 (Pubitemid 47437431)
50. Rosenberg BR et al (2011) Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRs. Nat Struct Mol Biol 18(2):230-236
51. Anant S et al (2004) Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127(4):1139-1149 (Pubitemid 39345883)
52. Oshima M et al (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87(5):803-809 (Pubitemid 26404280)
53. Mayer W et al (2000) Demethylation of the zygotic paternal genome. Nature 403(6769): 501-502 (Pubitemid 30082186)
54. Oswald J et al (2000) Active demethylation of the paternal genome in the mouse zygote. Curr Biol 10(8):475-478 (Pubitemid 30247337)
55. Santos F et al (2002) Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol 241(1):172-182 (Pubitemid 34066770)
56. Hajkova P et al (2002) Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117(1-2):15-23 (Pubitemid 36158711)
57. Feng S, Jacobsen SE, Reik W (2010) Epigenetic reprogramming in plant and animal development. Science 330(6004):622-627
58. Popp C et al (2010) Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463(7284):1101-1105
59. Simonsson S, Gurdon J (2004) DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol 6(10):984-990 (Pubitemid 39359851)
60. Mikkelsen TS et al (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200):49-55 (Pubitemid 351931978)
61. Bhutani N et al (2010) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463(7284):1042-1047
62. Eads CA, Nickel AE, Laird PW (2002) Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. Cancer Res 62(5):1296-1299 (Pubitemid 34407781)
63. Yamada Y et al (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102(38):13580-13585 (Pubitemid 41420891)
64. Lin H et al (2006) Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol Cell Biol 26(8):2976-2983
65. Laird PW et al (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81(2):197-205
66. Linhart HG et al (2007) Dnmt3b promotes tumorigenesis in vivo by gene-speci fi c de novo methylation and transcriptional silencing. Genes Dev 21(23):3110-3122 (Pubitemid 350223528)
67. Eads CA et al (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60(18):5021-5026
68. Jones PA et al (1992) Methylation, mutation and cancer. Bioessays 14(1):33-36
69. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3 Spec No:1487-1495
70. Greenblatt MS et al (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54(18):4855-4878 (Pubitemid 24289415)
71. Holliday R, Grigg GW (1993) DNA methylation and mutation. Mutat Res 285(1):61-67 (Pubitemid 23029555)
72. Wong E et al (2002) Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci USA 99(23):14937-14942 (Pubitemid 35334588)
73. Millar CB et al (2002) Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297(5580):403-405 (Pubitemid 34790770)